These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 30568427)
21. The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis. Amaro R; Panagiotaraka M; Alcaraz V; Torres A Expert Rev Respir Med; 2018 Aug; 12(8):683-691. PubMed ID: 30010445 [TBL] [Abstract][Full Text] [Related]
22. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial. Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200 [TBL] [Abstract][Full Text] [Related]
23. Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study. Wilson R; Welte T; Polverino E; De Soyza A; Greville H; O'Donnell A; Alder J; Reimnitz P; Hampel B Eur Respir J; 2013 May; 41(5):1107-15. PubMed ID: 23018904 [TBL] [Abstract][Full Text] [Related]
24. Inhaled antibiotics in Cystic Fibrosis (CF) and non-CF bronchiectasis. Tay GT; Reid DW; Bell SC Semin Respir Crit Care Med; 2015 Apr; 36(2):267-86. PubMed ID: 25826593 [TBL] [Abstract][Full Text] [Related]
25. Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials. Barker AF; O'Donnell AE; Flume P; Thompson PJ; Ruzi JD; de Gracia J; Boersma WG; De Soyza A; Shao L; Zhang J; Haas L; Lewis SA; Leitzinger S; Montgomery AB; McKevitt MT; Gossage D; Quittner AL; O'Riordan TG Lancet Respir Med; 2014 Sep; 2(9):738-49. PubMed ID: 25154045 [TBL] [Abstract][Full Text] [Related]
26. A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart. Tran TT; Vidaillac C; Yu H; Yong VFL; Roizman D; Chandrasekaran R; Lim AYH; Low TB; Tan GL; Abisheganaden JA; Koh MS; Teo J; Chotirmall SH; Hadinoto K Int J Pharm; 2018 Aug; 547(1-2):368-376. PubMed ID: 29886096 [TBL] [Abstract][Full Text] [Related]
27. Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis. Stass H; Nagelschmitz J; Kappeler D; Sommerer K; Patzlaff A; Weimann B J Aerosol Med Pulm Drug Deliv; 2019 Jun; 32(3):156-163. PubMed ID: 30848695 [No Abstract] [Full Text] [Related]
28. Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study. Stass H; Weimann B; Nagelschmitz J; Rolinck-Werninghaus C; Staab D Clin Ther; 2013 Oct; 35(10):1571-81. PubMed ID: 24054830 [TBL] [Abstract][Full Text] [Related]
29. Inhaled or nebulised ciprofloxacin for the maintenance treatment of bronchiectasis. Cartlidge MK; Hill AT Expert Opin Investig Drugs; 2017 Sep; 26(9):1091-1097. PubMed ID: 28778139 [TBL] [Abstract][Full Text] [Related]
30. Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis. Sangiovanni S; Morales EI; Fernández-Trujillo L Respir Med; 2021 Jan; 176():106283. PubMed ID: 33307314 [TBL] [Abstract][Full Text] [Related]
31. Inhaled antibiotics for treatment of adults with non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis. Tejada S; Campogiani L; Solé-Lleonart C; Gómez A; Gallego M; Vendrell M; Soriano JB; Rello J Eur J Intern Med; 2021 Aug; 90():77-88. PubMed ID: 33947626 [TBL] [Abstract][Full Text] [Related]
32. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial. Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B; Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664 [TBL] [Abstract][Full Text] [Related]
33. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial. Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664 [TBL] [Abstract][Full Text] [Related]
34. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis. Chalmers JD; Boersma W; Lonergan M; Jayaram L; Crichton ML; Karalus N; Taylor SL; Martin ML; Burr LD; Wong C; Altenburg J Lancet Respir Med; 2019 Oct; 7(10):845-854. PubMed ID: 31405828 [TBL] [Abstract][Full Text] [Related]